Position in ELAN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$200,300
-$5,258 QoQ
Shares Held
8,139
-5.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#376
of 515 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Moors & Cabot, Inc. holds $1,565,307 across 4 Drug Manufacturers - Specialty & Generic names. ELAN ranks #3 (12.8% of the industry book) .
All Filings in ELAN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $200,300 | 8,139 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $205,558 | 8,590 | Shares | Sole | 2026-05-08 | |
| 2025-09-30 | $206,435 | 10,250 | Shares | Sole | 2025-11-14 | |
| 2023-09-30 | $187,146 | 16,650 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $128,265 | 12,750 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $206,640 | 21,983 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $284,420 | 23,275 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $362,682 | 29,225 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $603,956 | 30,767 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $799,449 | 30,642 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $876,005 | 30,867 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $975,578 | 30,592 | Shares | Sole | 2021-12-08 | |
| 2021-06-30 | $905,131 | 26,092 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $653,554 | 22,192 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $657,779 | 21,447 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $547,902 | 19,617 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $408,150 | 19,028 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $283,233 | 12,650 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||